CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

BackgroundAcute Myeloid leukemia is a heterogeneous disease that requires novel targeted treatment options tailored to the patients’ specific microenvironment and blast phenotype.MethodsWe characterized bone marrow and/or blood samples of 37 AML patients and healthy donors by high dimensional flow c...

Full description

Bibliographic Details
Main Authors:	Laurène Pousse, Koorosh Korfi, Bruno C. Medeiros, Marco Berrera, Nadine Kumpesa, Jan Eckmann, Idil Karakoc Hutter, Vera Griesser, Vaios Karanikas, Christian Klein, Maria Amann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Oncology
Subjects:	acute myeloid leukemia (AML) leukemic stem cells (LSC) regulatory T cell (Treg) CD25 antibody dependent cellular cytotoxicity (ADCC)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1150149/full

Similar Items

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
by: Henrike Jacobi, et al.
Published: (2023-07-01)

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization
by: Judith Cruz Amaya, et al.
Published: (2023-06-01)

CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide
by: Jayaprakasam Madhumathi, et al.
Published: (2017-03-01)

Characterization of CD34<sup>+</sup> Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol
by: Cathrin Nollmann, et al.
Published: (2024-03-01)

Pelvic organ prolapse and uterine preservation: a cohort study (POP-UP study)
by: Daniel Gagyor, et al.
Published: (2021-02-01)

Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison
by: Marta Romo-González, et al.
Published: (2022-06-01)

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
by: Amanda G. Tomalka, et al.
Published: (2018-11-01)

α/β Discrimination by Hidex Liquid Scintillation Counter and Method for LSC Spectra Reconstruction
by: FENG Xiao-gui, et al.
Published: (2023-04-01)

Location First: Targeting Acute Myeloid Leukemia Within Its Niche
by: Alice Pievani, et al.
Published: (2020-05-01)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
by: Fabio Guolo, et al.
Published: (2022-09-01)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
by: Mark P. Chao, et al.
Published: (2020-01-01)

Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
by: Mitchell Evers, et al.
Published: (2020-01-01)

MRD Tailored Therapy in AML: What We Have Learned So Far
by: Lok Lam Ngai, et al.
Published: (2021-01-01)

miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool
by: María Sol Ruiz, et al.
Published: (2021-01-01)

Optical coherence tomography findings of bilateral foveal leukemic infiltration
by: Le JQ, et al.
Published: (2016-08-01)

ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
by: Wen-Han Yu, et al.
Published: (2018-02-01)

SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity
by: Panagiota Bouti, et al.
Published: (2023-12-01)

CD34<sup>+</sup>CD38<sup>−</sup>CD123<sup>+</sup> Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
by: François Vergez, et al.
Published: (2020-05-01)

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia
by: Stéphanie Maupetit‐Mehouas, et al.
Published: (2018-06-01)

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans
by: Katherine L. Williams, et al.
Published: (2015-10-01)

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
by: Siret Tahk, et al.
Published: (2021-09-01)

LSD1 inhibition modulates transcription factor networks in myeloid malignancies
by: Emily E. Hartung, et al.
Published: (2023-03-01)

Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells
by: Tobias Maetzig, et al.
Published: (2017-09-01)

Radon Mitigation Applications at the Laboratorio Subterráneo de Canfranc (LSC)
by: Javier Pérez-Pérez, et al.
Published: (2022-02-01)

Detection limit calculation according to ISO 11929 for in vitro 210Pb radiobioassay determinations by LSC
by: C. S. Sampaio, et al.
Published: (2023-03-01)

Assessment of Sr-90 in water samples: precision and accuracy
by: Marcelo Bessa Nisti, et al.
Published: (2019-02-01)

Study of leukemic stem cell population (CD34+/CD38-) and WT1 protein expression in human leukemic cell lines
by: Pawaret Panyajai, et al.
Published: (2018-01-01)

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms
by: Tatiana Pazina, et al.
Published: (2017-09-01)

OPHTHALMIC MANIFESTATIONS OF LEUKEMIA
by: E. E. Grishina, et al.
Published: (2017-01-01)

TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4+ T cells
by: Kayla A Holder, et al.
Published: (2021-01-01)

The first structure of HIV-1 gp120 with CD4 and CCR5 receptors
by: Yongjun Guan
Published: (2019-01-01)

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
by: Carina Lynn Gehlert, et al.
Published: (2022-08-01)

From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement
by: Loïs Coënon, et al.
Published: (2022-06-01)

The prognostic effect on childhood acute lymphoblastic leukemia of CD34+CD38− expressed in leukemia cells
by: Jiou Zhao, et al.
Published: (2022-12-01)

Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34+CD123+ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia
by: Johannes R. Schmidt, et al.
Published: (2018-02-01)

The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, <i>TP53</i> Deletion, and a Poor Prognosis
by: Lianqun Qiu, et al.
Published: (2021-12-01)

El uso del software de transcripción lingüística ELAN en el análisis de la interpretación de lengua de señas colombiana en el contexto universitario
by: Alex Giovanny Barreto Muñoz, et al.
Published: (2012-10-01)

La increíble y triste historia de la interpretación de lengua de señas: reflexiones identitarias desde Colombia
by: Alex G. Barreto
Published: (2015-03-01)

Glass Substrate Dust Removal Using 233 fs Laser-Generated Shockwave
by: Myeongjun Kim, et al.
Published: (2021-11-01)

EL USO DEL SOFTWARE DE TRANSCRIPCIÓN LINGÜÍSTICA ELAN EN EL ANÁLISIS DE LA INTERPRETACIÓN DE LENGUA DE SEÑAS COLOMBIANA EN EL CONTEXTO UNIVERSITARIO
by: Alex Giovanny Barreto Muñoz, et al.
Published: (2012-10-01)